Skip to main content
Caplight Logo









Elligo Health Research

Elligo Health Research

Private
Austin, TexasHealthcare & Life Scienceshttps://www.elligo.com/

Last Round

Debt

Oct 2, 2023

Total Funding Raised

$216.75M

Company Overview

Elligo Health Research is a healthcare-enabling research organization that provides clinical trial recruitment, infrastructure, and technology solutions to accelerate the development of pharmaceutical, biotechnology, and medical device products.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

clinical trial managementpatient recruitmentintegrated research organizationIROEHR integrationclinical research sitereal-world evidenceRWEdecentralized clinical trialsDCTclinical trial softwaresite-less trialsreal-world dataRWDclinical trial techpatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Elligo Health Research Comparables

Compare Elligo Health Research with similar companies based on industry and business-model similarity.

Elligo Health Research comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Circuit Clinical
88%
Innovo Research
86%
Care Access
85%

Elligo Health Research Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 2, 2023
Series ESep 23, 2021
Series DDec 8, 2020
GrantOct 1, 2019
Series CMay 7, 2019
Series B
Mar 20, 2018

Elligo Health Research Investors

Notable investors and investment history

Elligo Health Research investors
InvestorRounds
Morgan Stanley Expansion CapitalSeries E
Ally Bridge GroupSeries E
Hatteras Venture PartnersSeries E, Series C, Series A, Series B
Norwest Venture PartnersSeries E
Noro-Moseley PartnersSeries E, Series C, Series A, Series B
Shumway CapitalSeries E, Series A, Series B
Horizon Technology Finance CorporationDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2021

    $135M round led by Ally Bridge Group and Morgan Stanley.

  • Dec 8, 2020

    Raised Series D led by Oracle Corporation.

Elligo Health Research Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Elligo Health Research Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Elligo Health Research's valuation, stock price, and market status.

Firmographic Details

HeadquartersAustin, Texas
Year Founded2016
Last FundingOct 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?